We are live on ! Find out more
ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

9 hedge funds and large institutions have $73.4K invested in ZyVersa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

80% more funds holding

Funds holding: 59 (+4)

0% less ownership

Funds ownership: 0%0% (-0%)

73% less capital invested

Capital invested by funds: $273K → $73.4K (-$200K)

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VF
1
Virtu Financial
New York
$30K +$90.3K +344 New
CAC
2
Cowen and Company
New York
$12.3K +$37.5K +143 New
TSS
3
Two Sigma Securities
New York
$9.7K +$29.7K +113 New
CSS
4
Cubist Systematic Strategies
Connecticut
$9.05K +$27.6K +105 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.22K +$262 +1 +2%
WAG
6
Winthrop Advisory Group
Massachusetts
$3.28K
SG
7
StoneX Group
New York
$3.12K +$9.45K +36 New
TRCT
8
Tower Research Capital (TRC)
New York
$1.41K +$787 +3 +23%
Barclays
9
Barclays
United Kingdom
$270 +$787 +3 New
Wells Fargo
10
Wells Fargo
California
$27
Bank of America
11
Bank of America
North Carolina
$24
Goldman Sachs
12
Goldman Sachs
New York
-$200K -296 Closed
UBS Group
13
UBS Group
Switzerland
-$6.33K -9 Closed